Who founded Arcus Biosciences?

Arcus Biosciences was founded by Juan Jaen, Terry Rosen.

Who are Arcus Biosciences's investors?

Arcus Biosciences's investors include Aisling Capital, Decheng Capital, Droia Ventures, EcoR1 Capital, Foresite Capital, GV (Google Ventures), SLVC, Sofinnova Ventures and 3 more.

Arcus Biosciences

11 known investors

Find your way into Arcus Biosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Arcus Biosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Arcus Biosciences is a clinical-stage biopharmaceutical company that designs small molecule and monoclonal antibody combination therapies for people with cancer. Founded in 2015, it runs an in-house discovery and development organization spanning research through commercialization for oncology patients.

Biotech Healthtech

Founders & leadership

Juan JaenPresident, Co-Founder, Board of Directors

Terry RosenCo-founder & Chief Executive OfficerExecutive Officer, Director at Flexus Biosciences

Bob GoeltzChief Financial OfficerExecutive Officer at Unity Biotechnology

Richard MarkusChief Medical Officer

Carolyn TangGeneral Counsel

Yvonne GehringSVP, Human Resources

Jonathan YinglingChief Scientific Officer

Alex AzoyChief Accounting Officer

Investors · 11

Aisling Capitallisted by Aisling CapitalNew York

How we know: Aisling Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Decheng Capitallisted by Decheng CapitalSilicon Valley

How we know: Decheng Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Droia Ventureslisted by Droia VenturesLuxembourg · $540K

How we know: Droia Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

EcoR1 Capitallisted by EcoR1 CapitalSan Francisco

Foresite Capitallisted by Foresite CapitalWest Hollywood

How we know: Foresite Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

GV (Google Ventures)listed by GV (Google Ventures)Mountain View · $250K – $50M

How we know: GV (Google Ventures)'s portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

SLVClisted by SLVC

How we know: SLVC's portfolio page · Not right? Tell us

Sofinnova Ventureslisted by Sofinnova VenturesMenlo Park · $100K – $15M

How we know: Sofinnova Ventures's portfolio page · Not right? Tell us

Taiho Ventures, LLClisted by Taiho Ventures, LLCMenlo Park

The Column Grouplisted by The Column GroupSan Francisco · $30M

How we know: The Column Group's portfolio page · the VCSheet dataset · Not right? Tell us

Wellington Managementlisted by Wellington ManagementBoston · $5M – $50M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Frequently asked questions

What does Arcus Biosciences do?: Arcus Biosciences is a clinical-stage biopharmaceutical company that designs small molecule and monoclonal antibody combination therapies for people with cancer. Founded in 2015, it runs an in-house discovery and development organization spanning research through commercialization for oncology patients.
Who founded Arcus Biosciences?: Arcus Biosciences was founded by Juan Jaen, Terry Rosen.
Who are Arcus Biosciences's investors?: Arcus Biosciences's investors include Aisling Capital, Decheng Capital, Droia Ventures, EcoR1 Capital, Foresite Capital, GV (Google Ventures), SLVC, Sofinnova Ventures and 3 more.